Mason Freeman - 11 Jan 2022 Form 4 Insider Report for CinCor Pharma, Inc.

Role
EVP Clinical Development
Signature
/s/ Cathy Rude, Attorney-in-Fact
Issuer symbol
N/A
Transactions as of
11 Jan 2022
Net transactions value
+$41,600
Form type
4
Filing time
13 Jan 2022, 15:28:20 UTC
Previous filing
06 Jan 2022
Next filing
27 Feb 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CINC Common Stock Purchase $40,000 +2,500 $16.00 2,500 11 Jan 2022 Direct
transaction CINC Common Stock Purchase $1,600 +100 $16.00 100 11 Jan 2022 By spouse F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The securities are held by the Reporting Person's spouse. The Reporting Person shares voting and investment control of the shares and may be deemed to beneficially own the shares. The Reporting Person disclaims beneficial ownership of such shares except to the extent of his proportionate pecuniary interest therein.